Target type: molecularfunction
Catalysis of the reaction: H2O + N-(long-chain-acyl)ethanolamine = ethanolamine + a fatty acid. [EC:3.5.1.60, MetaCyc:3.5.1.60-RXN]
N-(long-chain-acyl)ethanolamine deacylase activity is a crucial enzymatic process involved in the hydrolysis of N-(long-chain-acyl)ethanolamines, commonly known as fatty acid amides (FAAs). These FAAs, including anandamide (AEA), are lipid signaling molecules that play important roles in various physiological functions, such as pain perception, appetite regulation, and neurotransmission. The enzyme catalyzes the removal of a fatty acid from the N-(long-chain-acyl)ethanolamine molecule, producing ethanolamine and a free fatty acid. This hydrolytic reaction effectively terminates the signaling activity of the FAA, thus contributing to the regulation of FAA-mediated processes. The enzyme, commonly known as FAAH (fatty acid amide hydrolase), is a serine hydrolase that utilizes a catalytic triad consisting of Ser, His, and Asp residues. This triad facilitates the nucleophilic attack of the hydroxyl group of Ser on the carbonyl carbon of the amide bond, leading to the formation of a tetrahedral intermediate. This intermediate then collapses to release the free fatty acid and ethanolamine. The activity of FAAH is crucial for maintaining homeostasis of FAA signaling. Inhibition of FAAH can lead to an accumulation of FAAs, potentially resulting in altered pain perception, appetite control, and mood. Conversely, increased FAAH activity can decrease FAA levels, potentially impacting these functions. The regulation of FAAH activity is therefore a promising target for the development of therapeutic strategies for various conditions, including pain, obesity, and neurological disorders.'
"
Protein | Definition | Taxonomy |
---|---|---|
N-acylethanolamine-hydrolyzing acid amidase | An N-acylethanolamine-hydrolyzing acid amidase that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q02083] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
cannabinol | Cannabinol: A physiologically inactive constituent of Cannabis sativa L. | dibenzopyran | |
diacerein | diacerein: chelates with bivalent metals; a quinone which possesses redox properties; metabolized to active rhein; proposed mechanisms include inhibiting IL1 and metalloproteinases; called a slow acting symptomatic drug in osteoarthritis; no effect of cyclooxygenase; | anthraquinone | |
cannabichromene | 1-benzopyran | ||
(6ar-trans)-isomer of tetrahydrocannabivarin 9 | |||
delta(9)-tetrahydrocannabinolic acid | Delta(9)-tetrahydrocannabinolic acid : A diterpenoid that is 6a,7,8,10a-tetrahydro-6H-benzo[c]chromene substituted at position 1 by a hydroxy group, positions 6, 6 and 9 by methyl groups and at position 3 by a pentyl group. A biosynthetic precursor to Delta(9)-tetrahydrocannabinol, the principal psychoactive constituent of the cannabis plant. | benzochromene; diterpenoid; hydroxy monocarboxylic acid; phytocannabinoid; polyketide | anti-inflammatory agent; biomarker; metabolite; neuroprotective agent |
cannabidiolic acid | cannabidiolic acid : A dihydroxybenzoic acid that is olivetolic acid in which the hydrogen at position 3 is substituted by a 3-p-mentha-1,8-dien-3-yl (limonene) group. cannabidiolic acid: structure | dihydroxybenzoic acid; phytocannabinoid; polyketide; resorcinols | |
sc 58272 | SC 58272: inhibits myristoyl-CoA:protein N-myristoyltransferase; structure given in first source | ||
cannabidiol | cannabidiol : An cannabinoid that is cyclohexene which is substituted by a methyl group at position 1, a 2,6-dihydroxy-4-pentylphenyl group at position 3, and a prop-1-en-2-yl group at position 4. Cannabidiol: Compound isolated from Cannabis sativa extract. | olefinic compound; phytocannabinoid; resorcinols | antimicrobial agent; plant metabolite |
cannabigerol | cannabigerol : A member of the class of resorcinols that is resorcinol which is substituted by a (2E)-3,7-dimethylocta-2,6-dien-1-yl group at position 2 and by a pentyl group at position 5. It is a natural product found in Cannabis sativa and Helichrysum species. cannabigerol: RN given refers to (E)-isomer; structure given in first source | phytocannabinoid; resorcinols | anti-inflammatory agent; antibacterial agent; antioxidant; appetite enhancer; cannabinoid receptor agonist; neuroprotective agent; plant metabolite |
cannabigerolic acid | cannabigerolic acid : A dihydroxybenzoic acid that is olivetolic acid in which the hydrogen at position 3 is substituted by a geranyl group. A biosynthetic precursor to Delta(9)-tetrahydrocannabinol, the principal psychoactive constituent of the cannabis plant. cannabigerolic acid: structure in first source | dihydroxybenzoic acid; diterpenoid; phytocannabinoid; polyketide; resorcinols | |
cannabidivarin | cannabidivarin: from Cannabis sativa | monoterpenoid |